Hoogendoorn Sascha, van Puijvelde Gijs H M, van der Marel Gijs A, van Koppen Chris J, Timmers C Marco, Overkleeft Herman S
Leiden Institute of Chemistry, Leiden University Einsteinweg 55 2300 RA Leiden The Netherlands
Leiden Academic Centre for Drug Research, Leiden University Einsteinweg 55 2300 RA Leiden The Netherlands.
RSC Chem Biol. 2020 Aug 3;1(4):263-272. doi: 10.1039/d0cb00068j. eCollection 2020 Oct 1.
Fluorescent cell surface receptor agonists allow visualization of processes that are set in motion by receptor activation. This study describes the synthesis of two fluorescent, low molecular weight ligands for the follicle-stimulating hormone receptor (FSHR), based on a dihydropyridine (DHP) agonist. We show that both BODIPY- and Cy5-conjugated DHP (-DHP-BDP and -DHP-Cy5) are potent FSHR agonists, able to activate receptor signalling with nanomolar potencies and to effect receptor internalisation at higher concentrations. FSHR-dependent uptake of -DHP-Cy5 is in stark contrast to the cellular uptake of -DHP-BDP which was efficiently internalised also in the absence of FSHR. Our results comprise a first-in-class fluorescent low molecular weight ligand for FSHR imaging and pertain the potential means for targeted delivery of drugs into the endolysosomal pathway of FSHR-expressing cells.
荧光细胞表面受体激动剂能够使受体激活引发的过程可视化。本研究描述了基于二氢吡啶(DHP)激动剂合成的两种用于促卵泡激素受体(FSHR)的荧光低分子量配体。我们表明,BODIPY和Cy5共轭的DHP(-DHP-BDP和-DHP-Cy5)都是强效的FSHR激动剂,能够以纳摩尔效力激活受体信号,并在较高浓度下促使受体内化。-DHP-Cy5依赖FSHR的摄取与-DHP-BDP的细胞摄取形成鲜明对比,后者在没有FSHR的情况下也能有效内化。我们的研究结果包括用于FSHR成像的一流荧光低分子量配体,并涉及将药物靶向递送至表达FSHR细胞的内溶酶体途径的潜在手段。